The FDA is having PAR redo the dosing. A tremendous amount of time and money was wasted on the previous trial! Also, no mention of DMOD in the new study...PAR is obviously moving away from that claim.
Where we at?, page-268
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $111.8K | 474.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 154744 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 21128 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.005 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 63872 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PAR (ASX) Chart |